Trial · NCT02469857
Trial comparisons16
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 16 of 16
Download this page as JSON| Comparison | Source |
|---|---|
| AB103 0.5 mg/kg vs Placebo: Number of Patients With One or More Adverse Events (AEs) | Trial comparisons |
| Reltecimod (AB103) 0.5 mg/kg vs Placebo: Number of Patients With a Screening mSOFA Score of at Least 5 Who Achieved Day 14 Modified Sequential Organ Failure Assessment (mSOFA) Score of 0 or 1 | Trial comparisons |
| Reltecimod (AB103) 0.5 mg/kg vs Placebo: Number of Deaths From Day 0 Through Day 90 | Trial comparisons |
| Reltecimod (AB103) 0.5 mg/kg vs Placebo: Number of Deaths From Day 0 Through Day 90 Among Patients With Baseline Cardiovascular Failure (Shock) | Trial comparisons |
| AB103 0.5 mg/kg vs Placebo: Number of Patients With One or More Secondary Infections | Trial comparisons |
| Reltecimod (AB103) 0.5 mg/kg vs Placebo: Number of Patients With Baseline Cardiovascular Failure (Shock) Who Achieved NICCE | Trial comparisons |
| Reltecimod (AB103) 0.5 mg/kg vs Placebo: Number of Deaths After Day 14 Through Day 90 Among Patients With a Screening mSOFA Score of at Least 5 | Trial comparisons |
| AB103 0.5 mg/kg vs Placebo: Number of Patients With One or More Serious Adverse Events (SAEs) | Trial comparisons |
| Reltecimod (AB103) 0.5 mg/kg vs Placebo: Number of Deaths After Day 14 Through Day 90 | Trial comparisons |
| Reltecimod (AB103) 0.5 mg/kg vs Placebo: Number of Patients Achieving Day 14 Modified Sequential Organ Failure Assessment (mSOFA) Score of 0 or 1 | Trial comparisons |
| Reltecimod (AB103) 0.5 mg/kg vs Placebo: Number of Patients With Baseline Cardiovascular Failure (Shock) Who Achieved Day 14 Modified Sequential Organ Failure Assessment (mSOFA) Score of 0 or 1 | Trial comparisons |
| Reltecimod (AB103) 0.5 mg/kg vs Placebo: Number of Deaths After Day 14 Through Day 90 Among Patients With Baseline Cardiovascular Failure (Shock) | Trial comparisons |
| Reltecimod (AB103) 0.5 mg/kg vs Placebo: Number of Patients With a Screening Modified Sequential Organ Failure Assessment (mSOFA) Score of at Least 5 Who Achieved NICCE | Trial comparisons |
| Reltecimod (AB103) 0.5 mg/kg vs Placebo: deaths from any cause | Trial comparisons |
| Reltecimod (AB103) 0.5 mg/kg vs Placebo: Number of Deaths From Day 0 Through Day 90 Among Patients With a Screening mSOFA Score of at Least 5 | Trial comparisons |
| Reltecimod (AB103) 0.5 mg/kg vs Placebo: serious adverse events | Trial comparisons |
trials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02469857/comparisons